BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 11703090)

  • 1. Regulation of transforming growth factor-beta signaling.
    Zhu HJ; Burgess AW
    Mol Cell Biol Res Commun; 2001 Nov; 4(6):321-30. PubMed ID: 11703090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.
    Javelaud D; Mauviel A
    Oncogene; 2005 Aug; 24(37):5742-50. PubMed ID: 16123807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossing Smads.
    Wrana JL
    Sci STKE; 2000 Mar; 2000(23):re1. PubMed ID: 11752591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
    Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K
    Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta family signal transduction in Drosophila development: from Mad to Smads.
    Raftery LA; Sutherland DJ
    Dev Biol; 1999 Jun; 210(2):251-68. PubMed ID: 10357889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergence and convergence of TGF-beta/BMP signaling.
    Miyazono K; Kusanagi K; Inoue H
    J Cell Physiol; 2001 Jun; 187(3):265-76. PubMed ID: 11319750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
    Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T
    Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta signal transduction.
    Dennler S; Goumans MJ; ten Dijke P
    J Leukoc Biol; 2002 May; 71(5):731-40. PubMed ID: 11994497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-regulated and inhibitory Smads are critical in regulating transforming growth factor beta-mediated Meckel's cartilage development.
    Ito Y; Bringas P; Mogharei A; Zhao J; Deng C; Chai Y
    Dev Dyn; 2002 May; 224(1):69-78. PubMed ID: 11984875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism.
    Schiller M; Verrecchia F; Mauviel A
    Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
    Alvarez J; Serra R
    Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can't get no SMADisfaction: Smad proteins as positive and negative regulators of TGF-beta family signals.
    Christian JL; Nakayama T
    Bioessays; 1999 May; 21(5):382-90. PubMed ID: 10376010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
    Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB
    Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
    Zhang S; Fei T; Zhang L; Zhang R; Chen F; Ning Y; Han Y; Feng XH; Meng A; Chen YG
    Mol Cell Biol; 2007 Jun; 27(12):4488-99. PubMed ID: 17438144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction by transforming growth factor-beta: a cooperative paradigm with extensive negative regulation.
    Engel ME; Datta PK; Moses HL
    J Cell Biochem Suppl; 1998; 30-31():111-22. PubMed ID: 9893262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function relationship of inhibitory Smads: Structural flexibility contributes to functional divergence.
    Hariharan R; Pillai MR
    Proteins; 2008 Jun; 71(4):1853-62. PubMed ID: 18175316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta signaling, Smads, and tumor suppressors.
    Padgett RW; Das P; Krishna S
    Bioessays; 1998 May; 20(5):382-90. PubMed ID: 9670811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cell proliferation by Smad proteins.
    Ten Dijke P; Goumans MJ; Itoh F; Itoh S
    J Cell Physiol; 2002 Apr; 191(1):1-16. PubMed ID: 11920677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.